Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
RBC Capital analyst Sean Dodge maintains Avid Bioservices (NASDAQ:CDMO) with a Outperform and raises the price target from $...
Stephens & Co. analyst Jacob Johnson reiterates Avid Bioservices (NASDAQ:CDMO) with a Overweight and maintains $12 price...
William Blair analyst Max Smock reiterates Avid Bioservices (NASDAQ:CDMO) with a Market Perform.
Avid Bioservices (NASDAQ:CDMO) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0....
Avid reported fourth quarter financial results on Tuesday after the market closed. The company reported a loss of $1.94 per sha...
